THURSDAY, Sept. 7, 2023 (HealthDay News) — The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 diabetes to drop their daily insulin shots. ExpertsContinue Reading

MONDAY, July 17, 2023 (HealthDay News) — People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required. A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, phase 3 clinical trialContinue Reading

THURSDAY, July 13, 2023 (HealthDay News) — A bunch of healthy fruits and vegetables could be just what the doctor ordered. Nonprofit groups and public health agencies have experimented with the idea of a produce prescription over the years. Now, a new study simulates what would happen if patients withContinue Reading

THURSDAY, July 6, 2023 (HealthDay News) — Loneliness might be a true heartbreaker for people with diabetes — raising their odds of a heart attack even more than unhealthy lifestyle habits do. That’s according to a new study of over 18,000 adults with the blood sugar disease. Researchers found thatContinue Reading

MONDAY, July 3, 2023 (HealthDay News) — The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists. Semaglutide (Ozempic, Wegovy) and other drugs of their class known as GLP-1 receptor agonists cause digestionContinue Reading